课题基金 / 基金详情

Effect of CFS-1 on osteoclast and its precursor cells

Effect of CFS-1 on osteoclast and its precursor cells
CFS-1对破骨细胞及其前体细胞的影响
批准号:
07672028
负责人:
YAMADA Shoji
金额:
$1.47万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1995
资助国家:
日本
项目状态:
已结题
起止时间:
1995 至 1997

项目摘要

项目成果

YAMADA Shoji的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Colony-stimulating factor-1 (CSF-1), Also called macrophage colony-stimulating factor, is required for growth, differentiation activation, and survival of cells of the mononuclear phagocytic system. This cytokine has been shown to be essential foe osteoclast development as well as for inducing both proliferation and differentiation of osteoclast progenitors. It also sustains survival of mature osteoclasts and stimulates spreading and migration of these cells. In the present in vitro study, the formation of large TRAP-positive cells with a high number of nuclei was observed when osteoclasts isolated from rat long bones were incubated with CSF-1. These large cells, cultured on plastic, bind calcitonin and form F-actin along the edges of the cells. Fusion to such large TRAP-positive multinucleated cells in the presence of CSF-1 and the formation of pits were also observed on dentine slices. Quantitative data obtained from cultures on plastic demonstrated that the number of osteoclasts slightly increased in the course of 72 hrs in the presence of 250 pM CSF-1, whereas it decreased rapidly after 24 hrs in the absence of CSF-1, which confirms that this cytokine is required for the survivai of osteoclasts. The number of nuclei per osteoclast was maximal after 16 hrs incubation with CSF-1, namely twice the value found in the absence of CSF-1. The maximal effect of the cytokine on the fusion process was observed at a concentration of 250 pM-500pM.A calculation of the medians of the average frequency of nuclei distribution per osteoclast resulted in 4 nuclei per osteoclast in the absence, and 6 in the presence of CSF-1. Genistein and herbimycin A,inhibitors of tyrosine kinases, inhibited the fusion induced by CSF-1. The data suggest that CSF-1 induces osteoclast fusion, and that tyrosine kinase (s) are involved in this process. The fusion process may continue throughout the entire life on an osteoclast.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
E.Jimi,I.Nakamura,H.Amano et al.: "Osteoclast function is activated by osteoblastic cells through a mechanism involving cell-to cell contact." Endocrinology. 137. 2187-2190 (1996)
E.Jimi、I.Nakamura、H.Amano 等人:“破骨细胞功能是由成骨细胞通过涉及细胞间接触的机制激活的。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
天野 均: "破骨細胞による骨吸収のメカニズム" 歯科医療. 11. 22-28 (1997)
天野仁:“破骨细胞骨吸收的机制”牙科。 11. 22-28 (1997)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
H Amano, S Yamada, R Felix: "Colony-stimulating factor-1 (CSF-1) stimulates the fusion process in osteoclasts." J.Bone Miner.Res.Vol.13(in press). (1998)
H Amano、S Yamada、R Felix:“集落刺激因子 1 (CSF-1) 刺激破骨细胞的融合过程。”
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
21
    Different effects of enantiomers of beta2-adrenergic agonist on muscle and bone.
    • 批准号:
      22592077
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.83万
    • 财政年份:
      2010
    • 负责人:
      YAMADA Shoji
    • 依托单位:
    Infrastructure Development for Historical Time-spatial Data Mning to Modern Japan
    Development of Data Mining Resources for Knowledge Discovery of Pre-Modern Japanese Concepts
    Effect of VEGF's on osteockast formation and activation
    • 批准号:
      13671950
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.86万
    • 财政年份:
      2001
    • 负责人:
      YAMADA Shoji
    • 依托单位:
    国内基金
    海外基金
    新型小分子蛋白—人肝细胞生长因子三环域(hHGFK1)抑制破骨细胞及治疗小鼠骨质疏松的疗效评估与机制研究
    • 批准号:
      82370885
    • 项目类别:
      面上项目
    • 资助金额:
      49.00万元
    • 批准年份:
      2023
    • 负责人:
      姚晨
    • 依托单位:
    Pre-osteoclast调控的血管-骨形成偶联在骨性关节炎发病进展中的机制研究
    • 批准号:
      81601942
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      18.0万元
    • 批准年份:
      2016
    • 负责人:
      崔壮
    • 依托单位:
    一个潜在的、防治骨质破坏的药物靶点的新发现
    • 批准号:
      30670997
    • 项目类别:
      面上项目
    • 资助金额:
      24.0万元
    • 批准年份:
      2006
    • 负责人:
      许多荣
    • 依托单位: